Back to Dashboard
COO · Healthcare

Cooper Cos Inc

USA Healthcare Filing: 2026-03-31
29/100
Smart-money confidence1 of 3 sources positive
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
39
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$14.9B
Industry
Medical Instruments & Supplies
Sector
Healthcare
Exchange
NasdaqGS
About COOPER COS INC

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a…

Who's behind the signal
Every informed buyer we can see on COO, across all three feeds.
Hedge funds · 7
AQR Capital Management Increased +125%
Citadel Advisors Increased +244%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 1 on record
Disclosures from 2020-02-25 to 2020-02-25
The newest disclosure we hold for this stock is 2020-02-25. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2020-02-25 Susie Lee · D-NV House Sold $1,001 - $15,000
Not a model pick — but on our radar. COOPER COS INC isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
0
New positions
2
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
Increased +125%
% of portfolio
0.1%
Position change
+125%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.0×
Increased +244%
% of portfolio
0.0%
Position change
+244%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.1×
Unchanged
% of portfolio
15.9%
Position change
15.9% of JANA Partners Management's portfolio
Trust weight: 1.2×
Decreased −59%
% of portfolio
0.1%
Position change
−59%
0.1% of Tudor Investment's portfolio
Trust weight: 1.1×
Decreased −46%
% of portfolio
0.0%
Position change
−46%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
Decreased −79%
% of portfolio
0.0%
Position change
−79%
0.0% of Millennium Management's portfolio
Trust weight: 1.3×
Decreased −2%
% of portfolio
0.0%
Position change
−2%
0.0% of Bridgewater Associates's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to COOPER COS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell COOPER COS INC or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订